Results 91 to 100 of about 5,453 (156)

Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1.

Chinese medical journal, 1991
It has been reported that Ginsenoside can increase body resistance to many harmful factors and protect tissues from damage when an organism is in stress. To understand the mechanism of this action, a study on the antioxidative effect of Ginsenoside Rb1 and Rg1 was carried out. Results showed that Ginsenoside Rb1 and Rg1 could inhibit lipid peroxidation
H L, Deng, J T, Zhang
openaire   +1 more source

Ginsenoside Rb1 targets the NRF2-PPARγ-ACSL4 axis to inhibit PTECs ferroptosis. [PDF]

Chin Med
Tan B, Wu Z, Wang S, Tan W, Lin L, Yang X, Zheng L, Li J, Li K, Yang J, Li L.   +10 more
europepmc   +1 more source

Ferulic acid in combination with ginsenoside Rb1 alleviates myocardial no-reflow by inhibiting platelet HMGB1 release and NET formation. [PDF]

Chin Med
Li J, You Y, Wang Y, Zou J, Xiao S, Yin X, Xu J, Liao F, Zhang H, You Y.   +9 more
europepmc   +1 more source

Gut microbiome and metabolome in aneurysm rat with hypertension after ginsenoside Rb1 treatment. [PDF]

Front Pharmacol, 2023
Zeng Z, Wang H, Yi R, Lou J, Wen S, Hu Z.   +5 more
europepmc   +1 more source

Pharmacological activation of SIRT1-AMPK by ginsenoside Rb1: a novel therapeutic strategy for pressure injury <i>via</i> dual suppression of ferroptosis and inflammation. [PDF]

Front Pharmacol
Zhu H, Li H, Shi Y, Zhi H, Zhao X, Wang Z, Liu J.   +6 more
europepmc   +1 more source

Preparation, characterization and in vivo pharmacokinetic study of ginsenoside Rb1-PLGA nanoparticles. [PDF]

Sci Rep, 2023
Du L, Lu H, Xiao Y, Guo Z, Li Y.
europepmc   +1 more source

Multi-omics analysis reveals that ginsenoside Rb1 improves prognostic outcomes in sepsis by modulating mitochondrial metabolism MTHFD2 targets. [PDF]

Sci Rep
Shu Q, Luo H, Zhong L, Mo J, Wei X, Zhu Z, Chen X, She H, He F, Zhu J.   +9 more
europepmc   +1 more source

Retraction Note: Attenuating effect of Ginsenoside Rb1 on LPS-induced lung injury in rats. [PDF]

J Inflamm (Lond), 2023
Yuan Q, Jiang YW, Ma TT, Fang QH, Pan L.
europepmc   +1 more source

Ginsenoside Rb1 Alleviated the AKI to CKD Transition by Targeting VEGFR2. [PDF]

J Cell Mol Med
Zhang K, Ji Y, Fu Z, Wang X, Zhang Y, Yang Y, Liu R, Chen X, Cai G, Hong Q.   +9 more
europepmc   +1 more source

Ginsenoside Rb1 enhanced immunity and altered the gut microflora in mice immunized by H1N1 influenza vaccine. [PDF]

PeerJ, 2023
Wan C, Lu R, Zhu C, Wu H, Shen G, Yang Y, Wu X, Fang B, He Y.   +8 more
europepmc   +1 more source